Ralliant (NYSE:RAL) Price Target Raised to $82.00

Ralliant (NYSE:RAL) had its target price raised by analysts at Citigroup from $81.00 to $82.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Citigroup’s price objective would indicate a potential upside of 24.65% from the company’s current price.

Several other brokerages have also issued reports on RAL. Oppenheimer lifted their price target on shares of Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. BMO Capital Markets began coverage on shares of Ralliant in a research note on Monday, July 20th. They set a “market perform” rating and a $78.00 price objective for the company. Weiss Ratings restated a “sell (d)” rating on shares of Ralliant in a report on Monday, May 4th. Evercore began coverage on Ralliant in a research report on Tuesday, June 9th. They issued an “outperform” rating and a $80.00 target price on the stock. Finally, Barclays upped their target price on Ralliant from $52.00 to $67.00 and gave the stock an “overweight” rating in a report on Wednesday, May 13th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $75.70.

Ralliant Stock Down 1.8%

Shares of RAL traded down $1.22 during midday trading on Friday, hitting $65.78. The stock had a trading volume of 2,067,753 shares, compared to its average volume of 1,718,423. The company has a 50 day simple moving average of $67.12 and a two-hundred day simple moving average of $54.26. Ralliant has a twelve month low of $37.27 and a twelve month high of $75.41. The firm has a market cap of $7.36 billion and a price-to-earnings ratio of -6.01. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.61 and a quick ratio of 1.05.

Ralliant (NYSE:RAL) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.05. The company had revenue of $567.80 million during the quarter. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, analysts anticipate that Ralliant will post 2.64 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of RAL. Danske Bank A S acquired a new stake in Ralliant in the 4th quarter valued at about $25,000. V Square Quantitative Management LLC acquired a new stake in shares of Ralliant in the fourth quarter valued at approximately $26,000. Allworth Financial LP lifted its position in shares of Ralliant by 134.4% in the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock valued at $26,000 after buying an additional 293 shares during the last quarter. Palisade Asset Management LLC bought a new position in shares of Ralliant during the 3rd quarter worth approximately $26,000. Finally, BOKF NA bought a new position in shares of Ralliant during the 3rd quarter worth approximately $29,000.

Key Stories Impacting Ralliant

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Quarterly results exceeded expectations. Ralliant reported second-quarter revenue of approximately $568 million, up 13% year over year, and adjusted EPS of $0.68 versus the $0.63 consensus estimate. Adjusted net earnings were $76 million, while the net earnings margin improved 60 basis points to 10.1%. Ralliant Reports Second Quarter 2026 Results and Raises Full Year Guidance
• Positive Sentiment: Management raised its 2026 outlook. Full-year adjusted EPS guidance of $2.76-$2.90 is above the $2.65 analyst consensus, while revenue guidance of about $2.3 billion is ahead of the roughly $2.2 billion estimate. Third-quarter guidance also topped expectations, with EPS of $0.72-$0.78 versus $0.68 expected and revenue of $570 million-$590 million versus $556.4 million expected. Ralliant forecasts 2026 revenue and productivity savings
• Positive Sentiment: Truist maintained a Buy rating and raised its price target to $82 from $68, implying substantial potential upside from recent trading levels. The firm’s higher target reflects increased confidence following the results and outlook. Benzinga analyst update
• Positive Sentiment: Ralliant’s enterprise productivity program is expected to generate $50 million-$60 million in annualized savings by 2028, providing a potential longer-term margin and earnings catalyst. Productivity program details
• Neutral Sentiment: Royal Bank of Canada increased its price target to $73 from $71 but retained a “Sector Perform” rating, signaling moderate upside but no strong bullish conviction. Benzinga analyst update
• Neutral Sentiment: Trading in RAL was briefly halted under a Limit Up-Limit Down pause, indicating elevated short-term volatility around the earnings news.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.